Huapont Life Sciences Co.,Ltd. (SHE:002004)
China · Delayed Price · Currency is CNY 4.270
+0.070 (1.67%)
Jul 27, 2026, 3:04 PM CST
Huapont Life Sciences Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 11,510 | 11,512 | 11,665 | 11,595 | 13,232 | 12,431 |
Revenue Growth | -0.52% | -1.31% | 0.60% | -12.38% | 6.44% | 14.29% |
Gross Profit Gross Profit Growth | 4,129 | 4,165 | 3,838 | 4,387 | 5,261 | 4,672 |
Operating Income Operating Income Growth | 1,348 | 1,317 | 1,068 | 1,307 | 1,875 | 1,484 |
Net Income Net Income Growth | 683.68 | 713.19 | -298.99 | 302.12 | 433.48 | 667.81 |
Earnings Per Share EPS Growth | 0.35 | 0.36 | -0.15 | 0.15 | 0.22 | 0.34 |
EPS Growth | - | - | - | -30.29% | -35.10% | 2.21% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Headquarters of The Group Headquarters of The Group Growth | 83.18 |
Tourism Department Tourism Department Growth | 1,229 |
Other Business Units Other Business Units Growth | 184.7 |
Medicine Business Medicine Business Growth | 417.67 |
Pharmaceutical Division Pharmaceutical Division Growth | 3,303 |
Agrochemical New Materials Division Agrochemical New Materials Division Growth | 6,500 |
Intersegment Offset Intersegment Offset Growth | -206.23 |
Total Total Growth | 11,512 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 4,899 | 5,776 | 5,500 | 5,610 | 5,692 | 6,022 |
Total Debt Total Debt Growth | 8,036 | 7,270 | 8,890 | 8,626 | 8,048 | 8,968 |
Net Cash (Debt) Net Cash Growth | -3,137 | -1,494 | -3,390 | -3,016 | -2,355 | -2,946 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.59 | -0.76 | -1.72 | -1.52 | -1.19 | -1.49 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,273 | 2,096 | 1,625 | 1,589 | 2,408 | 1,270 |
Capital Expenditures CapEx Growth | -574.92 | -638.28 | -956.27 | -1,284 | -1,131 | -1,256 |
Free Cash Flow Free Cash Flow Growth | 1,698 | 1,458 | 669.02 | 305.35 | 1,277 | 13.19 |
Free Cash Flow Growth | 121.89% | 117.90% | 119.10% | -76.08% | 9579.95% | -98.84% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 35.87% | 36.18% | 32.90% | 37.83% | 39.76% | 37.58% |
Operating Margin | 11.71% | 11.44% | 9.16% | 11.27% | 14.17% | 11.94% |
Pretax Margin | 9.29% | 9.19% | -1.38% | 7.70% | 12.26% | 10.31% |
Profit Margin | 5.94% | 6.19% | -2.56% | 2.61% | 3.28% | 5.37% |
FCF Margin | 14.75% | 12.66% | 5.73% | 2.63% | 9.65% | 0.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.450 | - | 0.220 | 0.220 | 0.220 |
Dividend Per Share Growth | 0% | - | - | 0% | 0% | 0% |
Dividend Yield | 11.90% | 9.95% | - | 5.46% | 5.21% | 3.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 12.32 | 13.22 | - | 30.54 | 23.29 | 21.47 |
Forward PE | - | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 |
P/FCF Ratio | 4.96 | 6.47 | 13.33 | 30.22 | 7.91 | 1086.87 |
PS Ratio | 0.73 | 0.82 | 0.77 | 0.80 | 0.76 | 1.15 |